Ascendis Pharma A/S (ASND)
After hours:
Chart Events
Performance Outlook
| Previous Close | 108.14 |
| Open | 108.20 |
| Bid | 109.19 x 800 |
| Ask | 109.90 x 1100 |
| Day's Range | 107.18 - 110.54 |
| 52 Week Range | 61.58 - 134.52 |
| Volume | |
| Avg. Volume | 267,242 |
| Market Cap | 6.275B |
| Beta (5Y Monthly) | 0.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.97 |
| Earnings Date | May 09, 2023 - May 15, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.39 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ASND
Related Research
- Ascendis Pharma A/SNKTR: Lowering target price to $0.93NEKTAR THERAPEUTICS has an Investment Rating of SELL; a target price of $0.928000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.RatingFair ValueEconomic Moat5 days agoArgus Research
- Zacks
Omega Therapeutics, Inc. (OMGA) Moves 15.2% Higher: Will This Strength Last?
Omega Therapeutics, Inc. (OMGA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- GlobeNewswire
Ascendis Pharma to Participate in the Oppenheimer 33rd Annual Healthcare Conference
COPENHAGEN, Denmark, March 10, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President & Chief Executive Officer, and Scott Smith, Executive Vice President & Chief Financial Officer, will participate in a virtual fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on Wednesday, March 15. Details: EventOppenheimer 33rd Annual Healthcare ConferenceLocationVirtualDateWednesday, March 15, 2023Time12:00-12:30 p.m. Eastern Time / 9:00-9:
- Insider Monkey
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2022 Earnings Call Transcript
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2022 Earnings Call Transcript February 16, 2023 Operator: Good day, and thank you for standing by. Welcome to the Ascendis Pharma Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session . Please […]
